AIM ImmunoTech Inc.
AIM
$2.55
-$0.05-1.92%
AMEX
| 06/30/2025 | 03/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 56.25% | -64.44% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 56.25% | -64.44% | |||
| Cost of Revenue | 0.00% | 42.86% | |||
| Gross Profit | 150.00% | -84.21% | |||
| SG&A Expenses | -43.95% | -38.55% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -26.52% | -38.39% | |||
| Operating Income | 26.89% | 38.19% | |||
| Income Before Tax | 24.59% | 37.91% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 24.59% | 37.91% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 24.59% | 37.91% | |||
| EBIT | 26.89% | 38.19% | |||
| EBITDA | 27.24% | 38.51% | |||
| EPS Basic | 30.84% | 43.49% | |||
| Normalized Basic EPS | 31.56% | 41.21% | |||
| EPS Diluted | 30.84% | 43.49% | |||
| Normalized Diluted EPS | 31.56% | 41.21% | |||
| Average Basic Shares Outstanding | -98.93% | 9.87% | |||
| Average Diluted Shares Outstanding | -98.93% | 9.87% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||